Rocket Pharmaceuticals, Inc.
RCKT$213M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK299 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 6, 2026
6wMarket Overview
Stock performance and key metrics
RCKT News
Catalyst Timeline
1 upcoming, 0 past
Fanconi Anemia Complementation Group A
1 drug in this indication
Leukocyte Adhesion Defect - Type I
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply